HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.

Abstract
Although new salicylates are now available for the treatment of ulcerative colitis, sulphasazaline still has an important therapeutic role. The role of salicylates in Crohn's disease is limited to the mild activity phase; further data are required to clarify its role in maintenance on remission. New steroids are a real alternative to traditional steroids in active ulcerative colitis and Crohn's disease.
AuthorsM Campieri
JournalGut (Gut) Vol. 50 Suppl 3 Pg. III43-6 (May 2002) ISSN: 0017-5749 [Print] England
PMID11953332 (Publication Type: Journal Article, Review)
Chemical References
  • Glucocorticoids
  • Salicylates
  • Sulfasalazine
  • Budesonide
  • Prednisolone
  • Beclomethasone
  • Aspirin
Topics
  • Acute Disease
  • Aspirin (therapeutic use)
  • Beclomethasone (therapeutic use)
  • Budesonide (therapeutic use)
  • Colitis, Ulcerative (drug therapy)
  • Crohn Disease (drug therapy)
  • Drug Therapy, Combination
  • Glucocorticoids (therapeutic use)
  • Humans
  • Inflammatory Bowel Diseases (drug therapy)
  • Prednisolone (therapeutic use)
  • Randomized Controlled Trials as Topic
  • Salicylates (therapeutic use)
  • Sulfasalazine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: